have owned ESRX long enough to have average cost of $6.08 so its been a big win and I still believe it will continue to be good over time. As you know, company has not been very good at the P.R. side, but has performed very well. Just wish that there was more news to help our cause.
ESRX has traditionally done much by way of marketing in general, not just PR. Their attitude has been "We've done just fine without it, thank you," which is hard to refute. However, it does leave them open to being outpaced by those who can effectively market. Merck-Medco has been much stronger on this front and it will be interesting to see what happens with PCS's marketing under Rite-Aid.